Owner ID Biomedical Corporation

Inventors Boyer, Martine; Hamel, Josee; Rioux, Stephane; Brodeur, Bernard; Martin, Denis

Agent Davies Collison Cave

Pub. Number AU-B-2001272270

PCT Pub. Number WO02/04495

Priority 60216465 06.07.00 US

Filing date 6 July 2001

Wipo publication date 21 January 2002

Acceptance publication date 8 March 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies